Missing Data in the Regulation of Medical Devices
- 28 February 2011
- journal article
- research article
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 21 (2) , 180-195
Abstract
Handling missing data is an important consideration in the analysis of data from all kinds of medical device studies. Missing data in medical device studies can arise for all the reasons one might expect in pharmaceutical clinical trials. In addition, they occur by design, in nonrandomized device studies, and in evaluations of diagnostic tests. For dichotomous endpoints, a tipping point analysis can be used to examine nonparametrically the sensitivity of conclusions to missing data. In general, sensitivity analysis is an important tool to study deviations from simple assumptions about missing data, such as the data being missing at random. Approaches to missing data in Bayesian trials are discussed, including sensitivity analysis. Many types of missing data that can occur with diagnostic test evaluations are surveyed. Careful planning and conduct are recommended to minimize missing data. Although difficult, the prespecification of all missing data analysis strategies is encouraged before any data are collected.Keywords
This publication has 19 references indexed in Scilit:
- Missing Data Handling Methods in Medical Device Clinical TrialsJournal of Biopharmaceutical Statistics, 2009
- Statistics in the World of Medical Devices: The Contrast with PharmaceuticalsJournal of Biopharmaceutical Statistics, 2007
- Comparing Two Medical Tests When Results of Reference Standard Are Unavailable for Those Negative via Both TestsJournal of Biopharmaceutical Statistics, 2007
- Statistical and Regulatory Issues in Nonrandomized Medical Device Clinical StudiesJournal of Biopharmaceutical Statistics, 2007
- Statistical and Regulatory Issues with the Application of Propensity Score Analysis to Nonrandomized Medical Device Clinical StudiesJournal of Biopharmaceutical Statistics, 2007
- Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast CancerJNCI: Journal of the National Cancer Institute, 2006
- Some issues in resolution of diagnostic tests using an imperfect gold standardStatistics in Medicine, 2001
- Discrepant AnalysisJournal of Clinical Epidemiology, 1999
- A multiple imputation strategy for clinical trials with truncation of patient dataStatistics in Medicine, 1995
- Missing Data, Imputation, and the BootstrapJournal of the American Statistical Association, 1994